Skip to the page

Data / Drug companies / Florida Pharmaceutical Products, LLC

Florida Pharmaceutical Products, LLC: 44 products in the FDA NDC directory, labeler code 71921

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Florida Pharmaceutical Products, LLC (labeler code 71921) lists 44 products in the FDA National Drug Code Directory, covering 25 finished drugs by generic name. By type: 44 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on April 14, 2026.

The request: Watch Florida Pharmaceutical Products, LLC (FDA labeler code 71921): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
71921
Products in commercial distribution
44
Packages
66
Finished drugs by generic name
25
Prescription products
44
Over the counter products
0
Controlled substance products
Schedule V 6
Flagged as original packager
43 of 43 products that carry the flag
Started marketing in the last 12 months
12
Earliest marketing start
January 15, 2021
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)4397.7%
New drug applications (NDA)12.3%

Products by type

TypeProductsShare
Prescription drugs44100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet1943.2%
Tablet, film coated715.9%
Capsule613.6%
Solution511.4%
Tablet, coated24.5%
Solution/ drops24.5%
Kit12.3%
Spray12.3%
Powder, for solution12.3%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Rasagiline mesylate71921-408TabletGeneric drugs (ANDA)April 14, 2026
Rasagiline mesylate71921-407TabletGeneric drugs (ANDA)April 14, 2026
Dapagliflozin71921-421TabletGeneric drugs (ANDA)April 6, 2026
Dapagliflozin71921-420TabletGeneric drugs (ANDA)April 6, 2026
Brivaracetam oral Solution71921-410SolutionGeneric drugs (ANDA)February 24, 2026
Acyclovir71921-146CapsuleGeneric drugs (ANDA)February 18, 2026
Glycopyrrolate71921-111TabletGeneric drugs (ANDA)February 12, 2026
Glycopyrrolate71921-110TabletGeneric drugs (ANDA)February 12, 2026
Lacosamide Oral Solution71921-411SolutionGeneric drugs (ANDA)January 30, 2026
Mercaptopurine71921-150TabletNew drug applications (NDA)January 30, 2026
Aminocaproic Acid71921-175SolutionGeneric drugs (ANDA)December 20, 2025
Tenofovir Disoproxil Fumarate71921-105Tablet, coatedGeneric drugs (ANDA)November 26, 2025
Rivaroxaban71921-405TabletGeneric drugs (ANDA)August 20, 2025
Allopurinol71921-241TabletGeneric drugs (ANDA)May 22, 2025
Dorzolamide Hydrochloride Ophthalmic71921-400SolutionGeneric drugs (ANDA)May 7, 2025
Varenicline tartrate71921-309Tablet, film coatedGeneric drugs (ANDA)November 1, 2024
Varenicline tartrate71921-308Tablet, film coatedGeneric drugs (ANDA)November 1, 2024
Varenicline71921-307KitGeneric drugs (ANDA)November 1, 2024
Lofexidine71921-250Tablet, coatedGeneric drugs (ANDA)August 21, 2024
Brimonidine tartrate and timolol maleate71921-188SolutionGeneric drugs (ANDA)November 23, 2023
Allopurinol71921-242TabletGeneric drugs (ANDA)October 31, 2023
Allopurinol71921-240TabletGeneric drugs (ANDA)October 31, 2023
Lacosamide71921-223TabletGeneric drugs (ANDA)September 21, 2023
Lacosamide71921-222TabletGeneric drugs (ANDA)September 21, 2023
Lacosamide71921-221TabletGeneric drugs (ANDA)September 21, 2023

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.